Search results
Stag Industrial Q2 Earnings Call Highlights
Stag Industrial (NYSE:STAG) said industrial real estate fundamentals continued to stabilize during the second quarter of 2026, citing stronger absorption, a
Wall Street Analysts See a 30.32% Upside in Banco Macro (BMA): Can the Stock Really Move This High?
Banco Macro (BMA) closed the last trading session at $90.8, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 28.32% Upside in Bunge Global (BG): Can the Stock Really Move This High?
Shares of Bunge Global (BG) have gained 2.8% over the past four weeks to close the last trading session at $107.78, but there could still be a solid upside left in the stock if short-term price
Why Is Nike (NKE) Up 0.4% Since Last Earnings Report?
A month has gone by since the last earnings report for Nike (NKE). Shares have added about 0.4% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent
Constellation Brands (STZ) Down 3.8% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Constellation Brands (STZ). Shares have lost about 3.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend
Enterprise Products Partners Q2 Earnings Call Highlights
Enterprise Products Partners (NYSE:EPD) reported record second-quarter EBITDA and adjusted cash flow from operations
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?
Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts See a 39.34% Upside in China Yuchai (CYD): Can the Stock Really Move This High?
China Yuchai (CYD) closed the last trading session at $48.32, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 26.95% Upside in Belden (BDC): Can the Stock Really Move This High?
Shares of Belden (BDC) have gained 1.5% over the past four weeks to close the last trading session at $117.11, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 30.96% Upside in Celestica (CLS): Can the Stock Really Move This High?
Celestica (CLS) closed the last trading session at $352.59, gaining 4.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Ares Management Q2 Earnings Meet Estimates, AUM Rises Y/Y
Ares Management Corporation’s ARES second-quarter 2026 after-tax realized income per share of $1.29 met the Zacks Consensus Estimate. The bottom line increased from $1.03 in the prior-year quarter.
EQS-News: Anleihegläubiger der Reinstated 2026 Senior Notes beschließen Änderungen der Anleihebedingungen mit großer Mehrheit
General Mills (GIS) Down 3.1% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for General Mills (GIS). Shares have lost about 3.1% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue
Why Is FactSet (FDS) Up 5.2% Since Last Earnings Report?
A month has gone by since the last earnings report for FactSet Research (FDS). Shares have added about 5.2% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?
Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts See a 39.34% Upside in China Yuchai (CYD): Can the Stock Really Move This High?
China Yuchai (CYD) closed the last trading session at $48.32, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall